India-first daily coverage of GLP-1 therapy — DCGI approvals, Indian generic launches (Sundae, Noveltreat, Obeda, Semabest…), price cuts, Mounjaro / tirzepatide updates, and trial readouts (STEP, SUSTAIN, SURMOUNT, SELECT).
GLP-1 drugs: From weight loss wonder to potential heart-care tool The Times of India
IFF Report unveils the impact of GLP-1 on influencing food choices among Indian consumers Asia Food Beverages
Weight-loss Drugs In India: What Works And How To Use Them Safely BW Healthcare World
Semaglutide linked to lower psychiatric hospitalisation in bipolar disorder, but experts urge caution The South First
Indirect comparative efficacy and safety of tirzepatide vs semaglutide for the treatment of obesity or overweight in patients without type 2 diabetes Nature
The Most Common GLP-1 Side Effects — and How to Cope health.yahoo.com
Using cannabis with GLP-1 drugs may heighten stomach issue risk NewsNation
Doctor warns of 'eye stroke' risk linked to GLP-1 weight loss drugs AOL.com
FDA Flagged GLP-1 Vision Loss Signal in 2025, but U.S. Ozempic and Mounjaro Labels Still Lack NAION Warning Medical Daily
FDA Advisory No.2026-1283 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product “Tirzepatide 60 mg (Dual GIP and GLP-1 Receptor…
FDA Advisory No.2026-1265 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product “Retatrutide 30 mg (Triple GLP-1, GIP and Glucagon…
Peptide Regulation Debate Intensifies After FDA Advisory Panel's Controversial Vote AJMC
Novo Nordisk Lays Out 2035 Revenue Ambitions as CagriSema Data Sharpens Obesity Race AD HOC NEWS
Novo Nordisk’s next-gen weight loss drug outperforms Zepbound in new trial The Hill
Novo Nordisk's CagriSema Posts Strong Trial Wins While Eli Lilly Tightens Grip on US GLP-1 Market AD HOC NEWS
"Divisional game" under scrutiny as UPC proceedings over semaglutide kick off in Milan JUVE Patent
News articles are aggregated from third-party RSS feeds. GLP-1 Check does not endorse or verify individual articles. Content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting any treatment.
